○Ingrid E Scheffer (Paediatrics, University of Melbourne/Austin Health, Australia)
Session information
Joint Symposium
[JS2] JSCN‒ISS Joint Symposium:Overview of the latest development in developmental and epileptic encephalopathy (DEE)
Sat. Jun 1, 2024 10:10 AM - 11:40 AM Room1 (Bldg.1 2F Century Hall)
Organizer:Hideo Yamanouchi(Department of Pediatrics, Saitama Medical University Hospital)
In 2022, the International League Against Epilepsy (ILAE) released the new classification and definition of electroclinically-defined epilepsy syndromes with onset in neonates, infancy, and childhood. Here, developmental and epileptic encephalopathy (DEE) was defined as developmental impairment-associated epilepsy due to the underlying etiology and abundant epileptiform activity. DEE includes early infantile DEE, epilepsy of infancy with migrating focal seizures, infantile epileptic spasm syndrome, Dravet syndrome, epilepsy with myoclonic-atonic seizures, Lennox–Gastaut syndrome, and DEE with spike-wave activation in sleep, and others. In this symposium, four experts of pediatric epilepsy will present the overview of the latest development in DEE, focusing on genetic etiology, neuroimaging, anti-seizure medication, and surgical treatment. This symposium aims to provide the recent findings and develop the future clinical practice and research about DEE.
○Yuji Ito (Department of Pediatrics, Nagoya University Graduate School of Medicine, Aichi, Japan)
○Wang‒Tso Lee (National Taiwan University Children’s Hospital/National Taiwan University College of Medicine)
○Ryoko Honda1, Tomonori Ono2, Keisuke Toda3, Noriko Ikeda1, Nanako Nishiguchi1, Tadateru Yasu1, Hiroshi Baba4 (1.Department of Pediatrics, NHO Nagasaki Medical Center, Nagasaki, Japan, 2.Nagasaki, Japan, 3.Nagasaki, Japan, 4.Nagasaki, Japan)